Martin Metz
Charité University, Berlin, Germany · Charité University · Charité
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Martin Metz as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:58 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05528913 · Benralizumab in Chronic Prurigo - Investigating Clinical Efficacy (BICPIC)Charite University, Berlin, Germany · withdrawn · Chronic Prurigo · principal investigator
- Ph2NCT02169115 · Urticaria Facticia Treatment With Omalizumab (UFO)Charite University, Berlin, Germany · completed · Symptomatic Dermographism · principal investigator
- Ph2NCT01580592 · Cold Urticaria Treatment With XolairCharite University, Berlin, Germany · completed · Cold Contact Urticaria · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:58 UTC. The ranking covers the 200 most relevant of 71 PubMed records, and a shared surname and initials can bring in a namesake. All 71 on PubMed
- Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control.J Allergy Clin Immunol · 2014294 citationsRCR 13.2
- Ligelizumab for Chronic Spontaneous Urticaria.N Engl J Med · 2019198 citationsRCR 9.8
- 172 citationsRCR 5.6
- Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.Clin Cancer Res · 2017134 citationsRCR 4.8
- Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep venous thrombosis.Thromb Haemost · 1997132 citationsRCR 5.7
- Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial.Nat Med · 2021120 citationsRCR 8.3
- Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.Theranostics · 2017111 citationsRCR 5.1
- The Urticaria Activity Score-Validity, Reliability, and Responsiveness.J Allergy Clin Immunol Pract · 2018106 citationsRCR 6.8
- 102 citationsRCR 5.3
- Remibrutinib in Chronic Spontaneous Urticaria.N Engl J Med · 2025101 citationsRCR 29.7